betaine has been researched along with Myocardial Infarction in 14 studies
glycine betaine : The amino acid betaine derived from glycine.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Then, isoproterenol solution was used for induction of myocardial infarction." | 7.91 | The protective impact of betaine on the tissue structure and renal function in isoproterenol-induced myocardial infarction in rat. ( Babaei, G; Ghartavol, MM; Gholizadeh-Ghaleh Aziz, S; Hassan Khadem Ansari, M; Hossein Farjah, G, 2019) |
| "The highest and lowest quintiles of urinary betaine excretion associated with risk of heart failure (p = 0." | 7.78 | Betaine and secondary events in an acute coronary syndrome cohort. ( Atkinson, W; Chambers, ST; Elmslie, JL; Frampton, CM; George, PM; Lever, M; Molyneux, SL; Richards, AM; Slow, S; Troughton, RW, 2012) |
| "We investigated the antioxidant preventive effect of betaine on isoprenaline-induced myocardial infarction in male albino rats." | 7.76 | Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats. ( Anandan, R; AnbinEzhilan, R; Buddhan, S; Ganesan, B; Sivakumar, R, 2010) |
| " In the present study, we investigated the protective effect of betaine, a potent lipotropic molecule, on changes in the levels of membrane-bound ATPase activities, lipid peroxidation, sulfhydryl activities, and mineral status in isoprenaline-induced myocardial infarction in Wistar rats, an animal model of myocardial infarction in man." | 7.75 | Protective effect of betaine on changes in the levels of membrane-bound ATPase activity and mineral status in experimentally induced myocardial infarction in Wistar rats. ( Anandan, R; Buddhan, S; Ganesan, B; Jeyakumar, R, 2009) |
| "Pretreatment with betaine daily for a period of 30 days to isoprenaline-induced rats prevented the changes in the activities of these lysosomal enzymes." | 5.35 | Protective effect of betaine on changes in the levels of lysosomal enzyme activities in heart tissue in isoprenaline-induced myocardial infarction in Wistar rats. ( Anandan, R; Ganesan, B, 2009) |
| "We sought to study relations of plasma choline and its metabolite betaine to long-term risk of acute myocardial infarction (AMI) and all-cause mortality according to smoking status, in patients undergoing coronary angiography for stable angina pectoris." | 5.20 | Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris. ( Bleie, Ø; Ebbing, M; Nygård, O; Pedersen, ER; Schartum-Hansen, H; Seifert, R; Strand, E; Svingen, GF; Ueland, PM, 2015) |
| " Then, isoproterenol solution was used for induction of myocardial infarction." | 3.91 | The protective impact of betaine on the tissue structure and renal function in isoproterenol-induced myocardial infarction in rat. ( Babaei, G; Ghartavol, MM; Gholizadeh-Ghaleh Aziz, S; Hassan Khadem Ansari, M; Hossein Farjah, G, 2019) |
| "The highest and lowest quintiles of urinary betaine excretion associated with risk of heart failure (p = 0." | 3.78 | Betaine and secondary events in an acute coronary syndrome cohort. ( Atkinson, W; Chambers, ST; Elmslie, JL; Frampton, CM; George, PM; Lever, M; Molyneux, SL; Richards, AM; Slow, S; Troughton, RW, 2012) |
| "We investigated the antioxidant preventive effect of betaine on isoprenaline-induced myocardial infarction in male albino rats." | 3.76 | Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats. ( Anandan, R; AnbinEzhilan, R; Buddhan, S; Ganesan, B; Sivakumar, R, 2010) |
| " In the present study, we investigated the protective effect of betaine, a potent lipotropic molecule, on changes in the levels of membrane-bound ATPase activities, lipid peroxidation, sulfhydryl activities, and mineral status in isoprenaline-induced myocardial infarction in Wistar rats, an animal model of myocardial infarction in man." | 3.75 | Protective effect of betaine on changes in the levels of membrane-bound ATPase activity and mineral status in experimentally induced myocardial infarction in Wistar rats. ( Anandan, R; Buddhan, S; Ganesan, B; Jeyakumar, R, 2009) |
| "Pretreatment with betaine daily for a period of 30 days to isoprenaline-induced rats prevented the changes in the activities of these lysosomal enzymes." | 1.35 | Protective effect of betaine on changes in the levels of lysosomal enzyme activities in heart tissue in isoprenaline-induced myocardial infarction in Wistar rats. ( Anandan, R; Ganesan, B, 2009) |
| " In conclusion, our study, for the first time, provides experimental evidence that the long-term administration of mildronate not only decreases free carnitine concentration, but also causes a significant increase in GBB concentration, which correlates with the cardioprotection of mildronate." | 1.33 | Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction. ( Dambrova, M; Kalvinsh, I; Kirjanova, O; Liepinsh, E; Loca, D; Pugovichs, O; Vilskersts, R, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haissman, JM | 1 |
| Haugaard, AK | 1 |
| Ostrowski, SR | 1 |
| Berge, RK | 2 |
| Hov, JR | 1 |
| Trøseid, M | 2 |
| Nielsen, SD | 1 |
| Ghartavol, MM | 1 |
| Gholizadeh-Ghaleh Aziz, S | 1 |
| Babaei, G | 1 |
| Hossein Farjah, G | 1 |
| Hassan Khadem Ansari, M | 1 |
| Sinha, A | 1 |
| Ma, Y | 1 |
| Scherzer, R | 1 |
| Rahalkar, S | 1 |
| Neilan, BD | 1 |
| Crane, H | 1 |
| Drozd, D | 1 |
| Martin, J | 1 |
| Deeks, SG | 1 |
| Hunt, P | 1 |
| Hsue, PY | 1 |
| Schartum-Hansen, H | 1 |
| Pedersen, ER | 1 |
| Svingen, GF | 1 |
| Ueland, PM | 1 |
| Seifert, R | 1 |
| Ebbing, M | 1 |
| Strand, E | 1 |
| Bleie, Ø | 1 |
| Nygård, O | 1 |
| Zheng, P | 1 |
| Liu, J | 1 |
| Mai, S | 1 |
| Yuan, Y | 1 |
| Wang, Y | 1 |
| Dai, G | 1 |
| Skagen, K | 1 |
| Ueland, T | 1 |
| Holm, S | 1 |
| Abbas, A | 1 |
| Gregersen, I | 1 |
| Kummen, M | 1 |
| Bjerkeli, V | 1 |
| Reier-Nilsen, F | 1 |
| Russell, D | 1 |
| Svardal, A | 1 |
| Karlsen, TH | 1 |
| Aukrust, P | 1 |
| Hov, JE | 1 |
| Halvorsen, B | 1 |
| Skjelland, M | 1 |
| Kuka, J | 2 |
| Makrecka-Kuka, M | 1 |
| Cirule, H | 2 |
| Grinberga, S | 1 |
| Sevostjanovs, E | 1 |
| Dambrova, M | 3 |
| Liepinsh, E | 3 |
| Ganesan, B | 3 |
| Buddhan, S | 2 |
| Anandan, R | 3 |
| Sivakumar, R | 1 |
| AnbinEzhilan, R | 1 |
| Jeyakumar, R | 1 |
| Vilskersts, R | 2 |
| Makrecka, M | 1 |
| Pugovics, O | 1 |
| Kalvinsh, I | 2 |
| Lever, M | 1 |
| George, PM | 1 |
| Elmslie, JL | 1 |
| Atkinson, W | 1 |
| Slow, S | 1 |
| Molyneux, SL | 1 |
| Troughton, RW | 1 |
| Richards, AM | 1 |
| Frampton, CM | 1 |
| Chambers, ST | 1 |
| Ukachukwu, V | 1 |
| Idris, S | 1 |
| McIlwee, A | 1 |
| Loca, D | 1 |
| Kirjanova, O | 1 |
| Pugovichs, O | 1 |
1 trial available for betaine and Myocardial Infarction
| Article | Year |
|---|---|
Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris.
Topics: Aged; Angina, Stable; Betaine; Biomarkers; C-Reactive Protein; Choline; Coronary Angiography; Corona | 2015 |
13 other studies available for betaine and Myocardial Infarction
| Article | Year |
|---|---|
Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
Topics: Adult; Betaine; Biomarkers; Blood Platelets; Cardiovascular Diseases; Carnitine; Choline; Cross-Sect | 2017 |
The protective impact of betaine on the tissue structure and renal function in isoproterenol-induced myocardial infarction in rat.
Topics: Animals; Betaine; Cardiotonic Agents; Isoproterenol; Kidney; Male; Myocardial Infarction; Myocytes, | 2019 |
Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV -Infected Adults.
Topics: Adult; Antiretroviral Therapy, Highly Active; Atherosclerosis; Betaine; Carnitine; Carotid Artery Di | 2019 |
Regulation of signal transducer and activator of transcription 3 and apoptotic pathways by betaine attenuates isoproterenol-induced acute myocardial injury in rats.
Topics: Animals; Apoptosis; Betaine; Biomarkers; Cardiotonic Agents; Dose-Response Relationship, Drug; Isopr | 2015 |
The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
Topics: Aged; Betaine; Biomarkers; Carnitine; Carotid Stenosis; Case-Control Studies; Cause of Death; Chroma | 2016 |
Decrease in Long-Chain Acylcarnitine Tissue Content Determines the Duration of and Correlates with the Cardioprotective Effect of Methyl-GBB.
Topics: Animals; Betaine; Biotransformation; Cardiotonic Agents; Carnitine; Down-Regulation; gamma-Aminobuty | 2017 |
Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats.
Topics: Alanine Transaminase; Analysis of Variance; Animals; Antioxidants; Aspartate Aminotransferases; Beta | 2010 |
Protective effect of betaine on changes in the levels of lysosomal enzyme activities in heart tissue in isoprenaline-induced myocardial infarction in Wistar rats.
Topics: Acid Phosphatase; Animals; Betaine; Cardiotonic Agents; Enzyme Activation; Glycoside Hydrolases; Hea | 2009 |
Protective effect of betaine on changes in the levels of membrane-bound ATPase activity and mineral status in experimentally induced myocardial infarction in Wistar rats.
Topics: Adenosine Triphosphatases; Animals; Betaine; Calcium; Cardiotonic Agents; Isoproterenol; Lipid Perox | 2009 |
The cardioprotective effect of mildronate is diminished after co-treatment with L-carnitine.
Topics: Animals; Betaine; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Chromatography | 2012 |
Betaine and secondary events in an acute coronary syndrome cohort.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Betaine; Chromatography, High Pressure Liquid; Coh | 2012 |
Acute myocardial infarction in a young patient with hyperhomocysteinaemia.
Topics: Acute Disease; Adult; Betaine; Coronary Vessels; Folic Acid; Heart; Homocysteine; Humans; Hyperhomoc | 2012 |
Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction.
Topics: Animals; Betaine; Cardiovascular Agents; Carnitine; Chromatography, High Pressure Liquid; Coronary C | 2006 |